Pharmaceutical products | Tenderlake

    
                        Pharmaceutical products
                    
                        

                            
                                Contract Value:
                                  - 
                                Notice Type:
                                Contract Notice
                            
                        

                            
                                Published Date:
                                17 July 2023
                                Closing Date:
                                13 September 2023
                            
                        

                            
                                Location(s):
                                        DE DEUTSCHLAND (DE Germany/DEUTSCHLAND)
                            
                        


    
    
                                                                                
                        Description:
                        
                        Generic tender
Conclusion of discount agreements in accordance with §130a paragraph 8
Fifth Social Security Code in the form of active ingredient-related
Framework agreements for certain finished medicinal products.
Acyclovir (oral dosage forms) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
bezafibrate - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Progesterone - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
progesterone - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
progesterone - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Rizatriptan (SMT) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Rizatriptan (SMT) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Rizatriptan (SMT) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Rizatriptan (TAB) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Rizatriptan (TAB) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Rizatriptan (TAB) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sotalol - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
bezafibrate - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sotalol - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sotalol - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sulfasalazine (used to treat inflammatory joint diseases) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
sulfasalazine (used to treat inflammatory joint diseases) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sulfasalazine (used to treat inflammatory joint diseases) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sulpiride - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
sulpiride - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sulpiride - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sultiam - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sultiam - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
bezafibrate - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Sultiam - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tadalafil (used to treat PAH) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
tadalafil (used to treat PAH) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
tadalafil (used to treat PAH) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tamoxifen - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
tamoxifen - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tamoxifen - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Terazosin - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Terazosin - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Terazosin - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Biperides - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
tetrabenazine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
tetrabenazine - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
tetrabenazine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tranexamsäure (FTA) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tranexamsäure (FTA) - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tranexamsäure (FTA) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tranexamic acid (ILO) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tranexamic acid (ILO) - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Tranexamsäure (ILO) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Valsartan + Amlodipine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Biperides - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Valsartan + Amlodipine - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Valsartan + Amlodipine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Zolmitriptan - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Zolmitriptan - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Zolmitriptan - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Biperides - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brimonidine (ATR) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brimonidine (ATR) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brimonidine (ATR) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brimonidine (EDP) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
acyclovir (oral dosage forms) - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brimonidine (EDP) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Brimonidine (EDP) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brivudine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brivudine - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
brivudine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Budesonide (NAS, NDS) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Budesonide (NAS, NDS) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Budesonide (NAS, NDS) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
budesonide and formoterol - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
budesonide and formoterol - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
acyclovir (oral dosage forms) - DAK, KKH
33600000-6
budesonide and formoterol - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
cabergoline - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Cabergoline - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Cabergoline - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
calcipotriol - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
calcipotriol - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
calcipotriol - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
clonidine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
clonidine - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Clonidine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Amitriptyline (unretarded oral DRF) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
colestyramine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
colestyramine - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
colestyramine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Dienogest and ethinyl estradiol - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
dienogest and ethinyl estradiol - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Dienogest and ethinyl estradiol - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
entecavir - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
entecavir - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Entecavir - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
etonogestrel and ethinyl estradiol - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Amitriptyline (unretarded oral DRF) - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
etonogestrel and ethinyl estradiol - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
etonogestrel and ethinyl estradiol - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Etoricoxib - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
etoricoxib - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
etoricoxib - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Febuxostat - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Febuxostat - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Febuxostat - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Formoterol HPI - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Formoterol HPI - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Amitriptylin (unretardierte oral DRF) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Formoterol HPI - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Formoterol IHP - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
formoterol IHP - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Formoterol IHP - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Methotrexate (IFE) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Methotrexate (IFE) - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Methotrexate (IFE) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
methotrexate (PEN) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
methotrexate (PEN) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
methotrexate (PEN) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
atorvastatin - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Methotrexate (TAB) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Methotrexate (TAB) - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Methotrexate (TAB) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
methylprednisolone - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
methylprednisolone - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
methylprednisolone - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (AMP/ DFL) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (AMP/DFL) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (AMP/DFL) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (IIL) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Atorvastatin - TK, hkk, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (IIL) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (IIL) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (ILO) - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (ILO) - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Midazolam (ILO) - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Miglustat - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Miglustat - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Miglustat - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Naproxen - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Naproxen - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
atorvastatin - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
Naproxen - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
nifedipine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
nifedipine - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
nifedipine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
olanzapine - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
olanzapine - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
olanzapine - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
prednisone - BARMER
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
prednisone - TK, HKK, HEK
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.
prednisone - DAK, KKH
Conclusion of discount agreements in accordance with Section 130a (8) Fifth Social Code in the form of drug-related framework agreements for certain finished medicinal products.

                    
                    
                        
                            
                            

                                 Download full details as .pdf
                        

                        
                            The Buyer:
                            BARMER Justiziariat-Vergabestelle
                            
                            
                            
                            
                            
                            
                                                                                
                                                                
                            CPV Code(s):
                                33600000 - Pharmaceutical products
                        

                